Literature DB >> 9167509

Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia.

D W Zaidel1, M M Esiri, P J Harrison.   

Abstract

OBJECTIVE: Schizophrenia may involve the two cerebral hemispheres differentially. This study was conducted to determine whether left and right hippocampal neuronal size, shape, and orientation are normally asymmetrical or asymmetrically affected in schizophrenia.
METHOD: The authors examined postmortem tissue from the left and right hippocampus of 17 normal individuals and 14 individuals with schizophrenia. They measured the size, shape, and variability in orientation of pyramidal neurons in hippocampal subfields CA1-CA4 and the subiculum in computer images of 10-micron coronal sections stained with cresyl violet.
RESULTS: Both neuronal size and shape showed significant effects of diagnosis and a three-way interaction between diagnosis, hemisphere, and subfield. Neurons of the schizophrenic subjects were smaller than those of the normal subjects in the left CA1, left CA2, and right CA3 subfields; their shape differed from that of the normal subjects in the left CA1, left subiculum, and right CA3 subfields. There were no group differences in variability of neuronal orientation, but neurons in the CA3 genu in the schizophrenic subjects were less variable on the right than on the left. In the normal subjects, except for larger neurons in the left than in the right CA2 subfield and some left-right differences in variability of neuronal orientation, no statistically significant asymmetries were observed.
CONCLUSIONS: The data confirm that hippocampal neuronal size is decreased in schizophrenia and reveal that the shape of neurons is altered, supporting the view that hippocampal cytoarchitectural abnormalities may be part of the cerebral substrate of schizophrenia. They also provide further evidence that the abnormalities are localized and lateralized.

Entities:  

Mesh:

Year:  1997        PMID: 9167509     DOI: 10.1176/ajp.154.6.812

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  29 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

2.  Ketamine disrupts θ modulation of γ in a computer model of hippocampus.

Authors:  Samuel A Neymotin; Maciej T Lazarewicz; Mohamed Sherif; Diego Contreras; Leif H Finkel; William W Lytton
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

3.  Hippocampal morphometry in schizophrenia by high dimensional brain mapping.

Authors:  J G Csernansky; S Joshi; L Wang; J W Haller; M Gado; J P Miller; U Grenander; M I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 4.  Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior.

Authors:  Syed Mohammed Qasim Hussaini; Chan-Il Choi; Chang Hoon Cho; Hyo Jin Kim; Heechul Jun; Mi-Hyeon Jang
Journal:  Neurosci Biobehav Rev       Date:  2014-09-28       Impact factor: 8.989

5.  Multi-plane, wide-field fluorescent microscopy for biodynamic imaging in vivo.

Authors:  Ruheng Shi; Cheng Jin; Hao Xie; Yuanlong Zhang; Xinyang Li; Qionghai Dai; Lingjie Kong
Journal:  Biomed Opt Express       Date:  2019-11-27       Impact factor: 3.732

6.  Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer).

Authors:  Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2014-02-20       Impact factor: 9.306

7.  Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

Authors:  Kei Hamazaki; Kwang H Choi; Hee-Yong Kim
Journal:  J Psychiatr Res       Date:  2010-01-06       Impact factor: 4.791

8.  Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia.

Authors:  Julien Matricon; Alfredo Bellon; Helge Frieling; Oussama Kebir; Gwenaëlle Le Pen; Frédéric Beuvon; Catherine Daumas-Duport; Thérèse M Jay; Marie-Odile Krebs
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 9.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

Authors:  Nina V Kraguljac; David M White; Meredith A Reid; Adrienne C Lahti
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.